Navigate Towards the Immunotherapy Era: Value of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Brain Metastases

Brain metastases (BMs) in non-small-cell lung cancer (NSCLC) patients are associated with significant morbidity and poor prognosis. Immune checkpoint inhibitors (ICIs) have resulted in a paradigm shift in the management of advanced NSCLC. However, the value of ICIs in NSCLC patients with BMs remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Guanqun, Xing, Ligang, Sun, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001915/
https://www.ncbi.nlm.nih.gov/pubmed/35422812
http://dx.doi.org/10.3389/fimmu.2022.852811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001915/
https://www.ncbi.nlm.nih.gov/pubmed/35422812
http://dx.doi.org/10.3389/fimmu.2022.852811

Ejemplares similares